Stein A, Arnold D, Thuss-Patience PC, Moehler M, Grothe W, Seufferlein T, et al. Docetaxel, oxaliplatin and capecitabine (TEX regimen) in patients with metastatic gastric or gastro-esophageal cancer: Results of a multicenter phase I/II study. AO [Internet]. 2014 Mar. 1 [cited 2025 Feb. 20];53(3):392-8. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/27049